Streetbeat News

Price Targets

C

Oppenheimer analyst Chris Kotowski has maintained an Outperform rating on Citigroup (NYSE:C) and increased the price target from $85 to $93, indicating a positive outlook on the bank's stock.

Portfolio Pulse from Benzinga Newsdesk

January 16, 2024 | 3:25 pm

BAC

Oppenheimer analyst Chris Kotowski has maintained an Outperform rating on Bank of America (NYSE:BAC) but has reduced the price target from $50 to $49.

Portfolio Pulse from Benzinga Newsdesk

January 16, 2024 | 3:21 pm

TIAUSD

Taiki Maeda, CEO of HFA Research, predicts that Celestia's TIA token (CRYPTO: TIA) could experience significant growth due to its unique staking benefits. TIA's Proof-of-Stake protocol offers rewards from transaction fees and potential airdrops, which could yield high returns for early stakers. Maeda warns of future market adjustments to airdrop inflation and advises a balanced investment strategy, including taking profits strategically. He plans to unwind his TIA positions when certain market indicators are met, such as Coinbase topping the Apple App Store or major cryptocurrencies hitting new highs.

Portfolio Pulse from Murtuza Merchant

January 16, 2024 | 3:12 pm

WFC

Piper Sandler analyst Scott Siefers has maintained a Neutral rating on Wells Fargo (NYSE:WFC) and reduced the price target from $51 to $50.

Portfolio Pulse from Benzinga Newsdesk

January 16, 2024 | 3:10 pm

LOW

Piper Sandler analyst Peter Keith has maintained an Overweight rating on Lowe's Companies (NYSE:LOW) and increased the price target from $218 to $245.

Portfolio Pulse from Benzinga Newsdesk

January 16, 2024 | 3:06 pm

JPM

Piper Sandler analyst Scott Siefers has maintained an Overweight rating on JPMorgan Chase (NYSE:JPM) and increased the price target from $190 to $200.

Portfolio Pulse from Benzinga Newsdesk

January 16, 2024 | 3:03 pm

FND

Piper Sandler analyst Peter Keith has maintained a Neutral rating on Floor & Decor Holdings (NYSE:FND) while raising the price target from $74 to $98.

Portfolio Pulse from Benzinga Newsdesk

January 16, 2024 | 3:01 pm

BSX

Boston Scientific (NYSE:BSX) has been reviewed by 10 analysts over the last three months, with a mix of bullish and somewhat bullish ratings, and no bearish or somewhat bearish ratings. The average 12-month price target for BSX is now $63.8, up from $60.67, with a high estimate of $67.00 and a low estimate of $60.00. Analysts from firms such as RBC Capital, Raymond James, and others have maintained or raised their price targets and ratings, indicating a positive outlook on the company. Boston Scientific's financials show strong revenue growth and net margin but below-average ROE and ROA. The company's market capitalization is above industry averages, and it has a lower than average debt-to-equity ratio.

Portfolio Pulse from Benzinga Insights

January 16, 2024 | 3:00 pm

AXSM

Axsome Therapeutics (NASDAQ:AXSM) has received mixed analyst ratings over the past three months, with 6 analysts offering opinions ranging from bullish to bearish. The average 12-month price target for AXSM is $135.67, with a high estimate of $180.00 and a low of $108.00, indicating a 50.74% increase from the previous average target of $90.00. Analysts from firms including Piper Sandler, HC Wainwright & Co., Cantor Fitzgerald, and Citigroup have provided updates, with one raising the price target from $90.00 to $113.00. Axsome Therapeutics is a clinical-stage biopharmaceutical company focused on CNS disorders. Financially, the company has shown a significant revenue growth rate of 243.07% as of September 30, 2023, but struggles with profitability and efficiency, as indicated by its net margin of -107.62%, ROE of -22.69%, and ROA of -10.26%. Its debt-to-equity ratio of 0.69 is below the industry average.

Portfolio Pulse from Benzinga Insights

January 16, 2024 | 3:00 pm

CMG

Piper Sandler analyst Brian Mullan has maintained a Neutral rating on Chipotle Mexican Grill (CMG) and increased the price target from $1930 to $2226.

Portfolio Pulse from Benzinga Newsdesk

January 16, 2024 | 2:53 pm